Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis 
https://www.mdpi.com/2073-4409/9/12/2543
Abstract
The MRZ reaction (MRZR) comprises the three antibody indices (AIs) against measles, rubella, and varicella zoster virus, reflecting an intrathecal polyspecific B cell response highly specific for multiple sclerosis (MS). Thus, MRZR can be used to confirm a diagnosis of primary progressive MS (PPMS) but its pathophysiological and wider clinical relevance is unclear. This study aimed to investigate whether PPMS patients with a positive MRZR (MRZR+) differ from those with a negative MRZR (MRZR-) according to cerebrospinal fluid (CSF) biomarkers of B cell activity, neuroaxonal damage or glial activity, and clinical features. (1) 
Methods: 
In a multicenter PPMS cohort (n = 81) with known MRZR status, we measured B cell-activating factor (BAFF), chemokine CXC ligand 13 (CXCL-13), soluble B cell maturation antigen (sBCMA), soluble transmembrane activator and CAML interactor (sTACI), and chitinase-3-like protein 1 (CHI3L1) in the CSF with enzyme-linked immunosorbent assays (ELISAs). Glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) were detected in serum and CSF using single molecule array (SIMOA) technology. (2) 
Results: 
MRZR+ patients (45.7% of all PPMS patients) revealed higher levels of NfL in CSF compared to MRZR- patients (54.3%). There were positive correlations between each of sBCMA, sTACI, and intrathecal immunoglobin G (IgG) synthesis. Additionally, NfL concentrations in serum positively correlated with those in CSF and those of GFAP in serum. However, MRZR+ and MRZR- patients did not differ concerning clinical features (e.g., age, disease duration, Expanded Disability Status Scale (EDSS) at diagnosis and follow-up); CSF routine parameters; CSF concentrations of BAFF, CXCL-13, sBCMA, sTACI, CHI3L1, and GFAP; or serum concentrations of GFAP and NfL. (3) 
Conclusions: 
In PPMS patients, MRZR positivity might indicate a more pronounced axonal damage. Higher levels of the soluble B cell receptors BCMA and transmembrane activator and CAML interactor (TACI) in CSF are associated with a stronger intrathecal IgG synthesis in PPMS.
			
			
									
						
										
						MRZ Reaction in PPMS
A forum to discuss research on the origins of MS and its development.
			Return to “MS Etiology and Pathogenesis”
			
				Jump to
				
			
		
			
			
	
	- Multiple Sclerosis
 - ↳ General Discussion
 - ↳ Introductions
 - ↳ Drug Pipeline
 - ↳ Regimens
 - ↳ Undiagnosed
 - ↳ MS Etiology and Pathogenesis
 - Treatments
 - ↳ Chronic Cerebrospinal Venous Insufficiency (CCSVI)
 - ↳ Low Dose Naltrexone
 - ↳ Tysabri (Antegren, Natalizumab)
 - ↳ Copaxone
 - ↳ Glatopa
 - ↳ Avonex
 - ↳ Rebif
 - ↳ Betaseron
 - ↳ Plegridy
 - ↳ Novantrone
 - ↳ Aimspro
 - ↳ Diet
 - ↳ Stem Cells
 - ↳ Antibiotics
 - ↳ Campath (Lemtrada, Alemtuzumab)
 - ↳ Gene Therapy
 - ↳ Natural Approach
 - ↳ Biotin (Qizenday, Cerenday, MD1003)
 - ↳ Coimbra High-Dose Vitamin D Protocol
 - ↳ Statins
 - ↳ Tcelna (Tovaxin)
 - ↳ Revimmune (Cyclophosphamide, Cytoxan)
 - ↳ Medical Devices
 - ↳ Rituxan (Rituximab)
 - ↳ Ocrevus (Ocrelizumab)
 - ↳ Kesimpta (Ofatumumab)
 - ↳ Briumvi (Ublituximab-xiiy)
 - ↳ General Medications
 - ↳ Tecfidera (BG-12, Dimethyl fumarate)
 - ↳ Vumerity (Diroximel fumarate)
 - ↳ Bafiertam (Monomethyl fumarate)
 - ↳ Gilenya
 - ↳ Aubagio (Teriflunomide)
 - ↳ Mayzent (Siponimod)
 - ↳ Zeposia (Ozanimod)
 - ↳ Ponvory (Ponesimod)
 - ↳ Mavenclad (Cladribine)
 - ↳ Ampyra (Dalfampridine)
 - ↳ Medical Marijuana
 - ↳ Sativex
 - ↳ Chiropractic Treatment
 - Life
 - ↳ Daily Life
 - ↳ Veterans and MS
 - ↳ Trigeminal Neuralgia in MS
 - ↳ Reading Nook
 - ↳ Humor
 - ↳ Shopping
 - ↳ Friends and Family
 - ↳ Mental & Spiritual Health
 - ↳ Exercise and Physical Therapy
 - ↳ Under 25 with MS
 - ↳ MS in the Golden Years
 - ↳ Parenting Kids With MS
 - ↳ Parents with MS
 - ThisIsMS.com
 - ↳ Site Support
 - ↳ Suggestions